Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-24-027562
Filing Date
2024-08-22
Accepted
2024-08-22 09:28:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 rvph20240805_424b5.htm 424B5 605371
2 reviva01.jpg GRAPHIC 7093
  Complete submission text file 0001437749-24-027562.txt   616414
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-262348 | Film No.: 241230329
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)